U.S. Personal Products Stock News

Earlier this week, Bank of America Securities reaffirmed a positive analyst rating on Boston Scientific and highlighted progress in its Global Pulsed Field Ablation Trial targeting persistent atrial fibrillation. This focus on pulsed field ablation underscores how Boston Scientific is positioning its electrophysiology portfolio around minimally invasive treatments for complex cardiac rhythm disorders. We’ll now examine how upbeat analyst sentiment around electrophysiology demand and pulsed...

If you are wondering whether OSI Systems at around US$279.61 is offering fair value or stretching expectations, this breakdown is designed to help you size that up with clear numbers. The stock has posted returns of 9.6% over the last 7 days, 7.4% over the last 30 days, 9.4% year to date, 77.3% over 1 year, 224.4% over 3 years, and 194.4% over 5 years, which naturally raises questions about what is already reflected in the current price. Recent coverage has focused on OSI Systems as a...

Fresh commentary around U.S. cannabis rescheduling has put Innovative Industrial Properties (IIPR) back in focus, as investors weigh what stronger tenant credit profiles could mean for its dividend coverage and preferred share payouts. See our latest analysis for Innovative Industrial Properties. That backdrop helps explain why the stock’s recent momentum has been mixed, with a 7 day share price return of 5.28% alongside a 1 year total shareholder return of 12.52%, and deeper 3 year and 5...

IDEXX Laboratories recently prepared to release its fiscal Q4 2025 results, with analysts highlighting ongoing profit strength supported by its Companion Animal Group Diagnostics segment and growing demand for diagnostic instruments and cloud-based software. Analysts’ consistently optimistic earnings expectations and the company’s track record of surpassing profit estimates have reinforced confidence in the resilience of IDEXX’s diagnostics-led business model. Now, we’ll examine how optimism...

If you are wondering whether Morgan Stanley's share price still offers value after a strong run, this article will help you frame that question clearly. The stock recently closed at US$184.68, with returns of 4.0% over 7 days, 3.3% over 30 days, 1.5% year to date, 48.5% over 1 year, 125.8% over 3 years, and 183.3% over 5 years. Recent coverage has focused on Morgan Stanley's position as a major US diversified financials group, with attention on how global deal activity, wealth management...

PriceSmart (PSMT) has just opened its 2026 financial year with Q1 same store sales growth of 8%, coming on the heels of Q4 2025 revenue of US$1.3 billion and basic EPS of US$1.02, alongside trailing twelve month EPS of US$4.82 on revenue of US$5.3 billion. The company has seen quarterly revenue move from US$1.26 billion in Q1 2025 to US$1.36 billion in Q2, then US$1.32 billion in Q3 and US$1.33 billion in Q4, while basic EPS over that stretch ranged from US$1.21 to US$1.45. This sets up Q1...

If you are wondering whether Neurocrine Biosciences, at around its recent US$135.57 share price, offers value, you are not alone. This article is designed to help you frame that question clearly before you make up your own mind. The stock has seen mixed returns, with a 4.4% decline over the past 7 days, a 12.5% decline over 30 days, a 3.6% decline year to date, a 2.3% decline over 1 year, but gains of 23.8% over 3 years and 24.0% over 5 years. Recent attention on Neurocrine Biosciences has...

Franklin Covey (FC) opened fiscal Q1 2026 with revenue of US$64.0 million and a basic EPS loss of US$0.27, alongside net income excluding extraordinary items of a US$3.3 million loss, setting a cautious tone for the new financial year. The company has seen quarterly revenue move from US$69.1 million in Q1 2025 to US$84.1 million in Q4 2024 and US$64.0 million in Q1 2026, while basic EPS has ranged from a profit of US$0.92 in Q4 2024 to a loss of US$0.27 in the latest quarter, which puts the...

Earlier this week, Bank of America Securities downgraded Sigma Lithium from Neutral to Underperform, citing unresolved operational delays, liquidity uncertainty, and limited clarity on when mining operations will restart. The downgrade underscores a growing disconnect between improved lithium market fundamentals and Sigma Lithium’s stalled production progress and delayed project timelines. Next, we’ll examine how Bank of America’s concerns about unresolved operational delays could reshape...

Wondering if Paramount Skydance at US$12.27 offers value or just more volatility? This article walks through what the current price actually reflects about the business. The stock is down 8.4% over the last week and 16.2% over the last month, while the 1 year return sits at 17.1% and the 5 year return at a 70.0% decline, which can change how investors think about both upside and risk. Recent coverage has focused on Paramount and Skydance completing their merger, the reshaped ownership...

Allison Transmission Holdings (ALSN) has been under scrutiny as recent commentary points to a challenging demand backdrop, with anticipated sales decline and slower revenue and earnings growth than industrial peers weighing on sentiment. See our latest analysis for Allison Transmission Holdings. The recent executive reshuffle and the acquisition of Dana’s Off-Highway Drive & Motion Systems have arrived alongside a 90 day share price return of 28.58% and a 30 day share price return of 9.03%...

With no single headline event driving attention today, American States Water (AWR) is drawing interest as investors weigh its recent share performance against its current earnings profile and regulated utility footprint in California. See our latest analysis for American States Water. The recent 1-day and 30-day share price returns of 0.52% and 1.45% respectively contrast with a 2.10% decline over 90 days. The 1-year total shareholder return of 2.52% sits against a weaker 3-year total...

In December, Goldman Sachs downgraded Illinois Tool Works to Sell from Neutral, even as the company posted a record 27.4% operating margin in Q3 2025 and reaffirmed its full-year operating margin and EPS guidance. This mix of bearish analyst sentiment and resilient profitability highlights a tension between perceived valuation limits and management’s confidence in the underlying business. Next, we’ll examine how Goldman Sachs’ Sell call, set against Illinois Tool Works’ record margins and...

If you are wondering whether Vital Farms shares are offering fair value at around US$30.06, the key question is how its current price compares with what the business might be worth. The stock has been volatile, with a 5.9% decline over the last 7 days, a 9.8% decline over the last 30 days, a 0.8% gain year to date and a 23.7% decline over the last year. The 3 year and 5 year returns sit at 89.7% and 17.9% respectively. These mixed returns have kept Vital Farms on the radar for investors who...

Earlier this week, Sphere Entertainment Co. named Delta Air Lines the Official Airline of Sphere and opened the Delta SKY360° Club, creating a branded hospitality lounge experience integrated across onsite signage, digital platforms, and the venue’s massive Exosphere LED display. This partnership deepens Delta’s presence in high-profile experiential entertainment, potentially strengthening its premium brand positioning and engagement with loyal SkyMiles customers through exclusive Sphere...

Customers Bancorp, Inc. recently completed a planned leadership transition, appointing Sam Sidhu to its Board of Directors and as Chief Executive Officer of Customers Bancorp effective January 1, 2026, while founder Jay Sidhu moved from CEO to Executive Chairman and remained on the Board. This carefully staged, family-led succession, supported by new long-term employment and incentive agreements, underscores leadership continuity and performance alignment at a time when the bank is pursuing...

Why Johnson Controls Is Back in Focus Johnson Controls International (JCI) is back under the spotlight after comments from Nvidia’s CEO about reduced cooling needs in future data centers triggered sharp share price swings and fresh questions about long term demand. See our latest analysis for Johnson Controls International. The recent volatility comes on the back of a strong run, with the share price at US$111.29 after a 7.1% 7 day share price decline but a 41.2% 1 year total shareholder...

Ecolab (ECL) just secured another double A rating from CDP for water and climate performance, putting its sustainability profile in focus as investors weigh what that might mean for the stock. See our latest analysis for Ecolab. The CDP double A rating lands at a time when Ecolab’s short term momentum is firm, with a 1 month share price return of 7.28% and a 1 year total shareholder return of 17.04%. The 3 year total shareholder return of 82.97% points to longer term enthusiasm that predates...

In early January 2026, Alvotech announced that founder Róbert Wessman will step down as CEO at the end of the first quarter while remaining full-time Executive Chairman, with experienced pharmaceutical executive and current board member Lisa Graver set to assume the Chief Executive Officer role and resign from the board upon taking office. On the same day, Alvotech was removed from the OMX Nordic All-Share Index and secured a US$100,000,000 senior term loan facility maturing in December 2027...

If you are wondering whether Revolution Medicines at around US$107.39 still offers value after its recent run, you are not alone. The stock has seen large moves recently, with returns of 35.9% over the past week, 37.9% over the past month, 35.9% year to date, 157.0% over the past year and 256.9% over the past three years. These price moves have arrived alongside increased investor attention on the company, including ongoing coverage of its targeted oncology pipeline and its position in the...

Meritage Homes (MTH) is under pressure after recent data showed a 34.4% decline in its order backlog and a 16.8% drop in earnings per share over the last two years, along with weaker return on invested capital. See our latest analysis for Meritage Homes. The recent weakness in Meritage Homes' order backlog and earnings sits against a mixed price picture, with a 3.26% 1 day share price return and a modest 3.22% year to date share price return. The 1 year total shareholder return of an 8.09%...

JD.com (JD) has drawn fresh attention after announcing the repurchase and cancellation of about 183.2 million Class A ordinary shares, roughly 6.3% of its share count, totaling around US$3.0b in 2025. See our latest analysis for JD.com. The buyback headlines sit alongside a mixed price picture, with a 7 day share price return of 3.38% and a 90 day share price return decline of 6.84%. The 1 year total shareholder return decline of 12.08% and 5 year total shareholder return decline of 63.44%...

Why Butterfly Network is on investors’ radar Butterfly Network (BFLY) has drawn fresh attention after recent trading, with the share price at US$4.15 and returns of 0.09% over the past week and 0.34% over the past month. See our latest analysis for Butterfly Network. That recent 9.21% 7 day share price return and 33.87% 30 day share price return sits on top of an 82.02% 90 day move, even though the 1 year total shareholder return is 3.75%. This means short term momentum looks stronger than...

In recent weeks, Novavax reported mixed quarterly results, with revenue exceeding analyst expectations by a very large margin even as earnings per share came in below forecasts, while Singapore earlier this month made the company’s JN.1 Nuvaxovid COVID-19 vaccine available at selected GP clinics under its National Vaccination Programme through May 31. At the same time, analysts have materially raised their consensus earnings estimates for Novavax, suggesting the market is reassessing the...